Integrative analysis of GEO data on the microbial community in colorectal cancer tissues and its impact on the tumor immune microenvironment - Scorecard - MDSpire
Advertisement
Integrative analysis of GEO data on the microbial community in colorectal cancer tissues and its impact on the tumor immune microenvironment
Clinical Scorecard: Comprehensive Evaluation of GEO Data on Microbial Communities in Colorectal Cancer Tissues and Their Influence on the Tumor Immune Microenvironment
At a Glance
Category
Detail
Condition
Colorectal Cancer (CRC)
Key Mechanisms
Gut microbiota dysbiosis and disruption of the tumor immune microenvironment.
Target Population
Patients with colorectal cancer.
Care Setting
Multi-omics integration analysis and independent cohort validation.
Key Highlights
Significantly reduced α diversity and altered community structure in CRC patients.
Identification of seven key differentially abundant genera linked to CRC.
Pathogenic bacteria associated with reduced adaptive immune infiltration.
Core bacterial genera showed high cross-cohort consistency in abundance changes.
Differentially expressed genes enriched in immune signaling pathways.
Guideline-Based Recommendations
Diagnosis
Characterization of gut microbiota dysbiosis in CRC patients.
Management
Consideration of microbiome-based diagnostic strategies.
Monitoring & Follow-up
Assessment of microbial abundances and immune cell proportions.
Risks
Potential for pathogenic bacteria to promote tumor progression.
Patient & Prescribing Data
Patients diagnosed with colorectal cancer.
Understanding the microbiota-immune axis may inform therapeutic targets.
Clinical Best Practices
Utilize multi-omics approaches for comprehensive analysis.
Validate findings across independent cohorts to ensure robustness.
